International Federation of Pharmaceutical Manufacturers & Associations
© National Cancer Institute
About the disease
Acute myelogenous leukemia (AML) is a progressively rapid blood and bone marrow cancer that affects granulocytes or white blood cells.i, ii
Although the exact cause of AML is unclear, several risk factors exist. These includeexposure to high doses of radiation, smoking and long-term benzene exposure.i, ii
AML can affect both children and adults. Estimates suggest there are more than 13,000 new cases annually in the US alone.iii
In development for the treatment of acute myelogenous leukemia.
i. US Centers for Disease Control and Prevention. Blood Cancers.
ii. US Centers for Disease Control and Prevention. Leukemia.
iii. US National Cancer Institute. What You Need To Know About™ Leukemia.
© IFPMA, 2014